Med Tech Company Hit With Shareholder Suit Over Alleged Misstatements

(April 19, 2019, 11:28 AM EDT) -- TAMPA, Fla. — A medical technology company and its CEO misrepresented the clinical study results for its plasma-based surgical product in violation of federal securities laws, a shareholder argues in an...

To view the full article, register now.